Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance

Drug Resistance Updates

Volumn 4, Issue 6, 2001, Pages 368-377

  Ogretmen, Besim ^a   Hannun, Yusuf A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; GLUCOSYLCERAMIDE; SPHINGOMYELIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL AGING; CELL DEATH; CELL DIFFERENTIATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0035744047     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2001.0225     Document Type: Review

References (111)

1. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation
2. The role of ceramide in cell signaling
3. The sphingomyelin cycle and the second messenger function of ceramide
4. (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase
5. Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth
6. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme
7. Sphingolipid metabolism: Roles in signal transduction and disruption by fumonisins
8. Ceramide-mediated growth inhibition and CAPP are conserved in Saccharomyces cerevisiae
9. Ceramide stimulates a cytosolic protein phosphatase
10. Ceramide-activated protein phosphatase: Partial purification and relationship to protein phosphatase 2A
11. Role of ceramide activated protein phosphatase in ceramide-mediated signal transduction
12. Ceramide activates heterotrimeric protein phosphatase 2A
13. The dimeric and catalytic subunit forms of protein phosphatase 2A from rat brain are stimulated by C2-ceramide
14. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex
15. Lipopolysaccharide induces jun N-terminal kinase activation in macrophages by a novel Cdc42/Rac-independent pathway involving sequential activation of protein kinase C zeta and phosphatidylcholinedependent phospholipase C
16. Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells
17. Cathepsin D Targeted by acid-sphingomyelinase-derived ceramide
18. Ceramide as an activator lipid of cathepsin D
19. Programmed cell death induced by ceramide
20. prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of bcl-2
21. Ceramide induces apoptosis via CPP32 activation
22. Bcl-2 interrupts the ceramide-mediated pathway of cell death
23. Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-κB/JNK kinase and cell survival
24. Expression of protein kinase Cβ1 confers resistance to TNFα- and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells
25. p53-dependent ceramide response to genotoxic stress
26. Functions of ceramide in coordinating cellular response to stress
27. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest
28. Cell ceycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclindependent kinases
29. Regulation of cyclin-dependent kinase 2 activity by ceramide
30. Ceramide-coated ballon catheters limit neointimal hyperplasia after strech injury in carotid arteries
31. Ceramide-induced inhibition of Akt is mediated through PK Czeta: Implications for growth arrest
32. Sphingomyelin turnoverinduced by vitamin D3 in HL-60 cells. Role in cell differentiation
33. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor
34. Role of ceramide in cellular senescence
35. C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by LagIp and LacIp
36. Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells
37. Molecular mechanisms of ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line
38. Sphingolipids signal heat stressinduced ubiquitin-dependent proteolysis
39. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway
40. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway
41. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
42. Role of ceramide in cellular senescence
43. Role for ceramide in cell cycle arrest
44. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells
45. Ceramide-mediated biology: Determination of structural and stereospecific requirements through the use of N-acyl-phenylaminoalcohol analogs
46. Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth
47. (1S, 2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol (D-e-MAPP) as an inhibitor of ceramidase
48. Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis
49. Involvement of yeast sphingolipids in the heat stress response of Saccharomyces cerevisiae
50. Heat-induced elevation of ceramide in Soccharomyces cerevisiae via de novo synthesis
51. Mutations in SPTLCI, encoding serine palmitoyltransferase, long chain base subunit-I, cause hereditary sensory neuropathy type 1
52. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals
53. 1 cells treated with retinoic acid
54. Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death
55. Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase
56. Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis
57. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-cycloheximide-induced cerebral endothelial cell death
58. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis
59. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells
60. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells
61. CD95 (Fas/APO-I) signals ceramide generation independent of the effector stage of apoptosis
62. Ceramide enables fax to ca and kill
63. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release
64. FAS activation induces dephosphorylation of SR proteins: Dependence on the de novo generation of ceramide and activation of protein phosphatase I
65. Enzymes of ceramide biosynthesis
66. Ceramide-mediated apoptosis of hepatocytes in vivo: A matter of the nucleus?
67. Neutral sphingomyelinase: Past, present and future
68. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV-40-transformed human fibroblasts
69. Molecular cloning and characterization of a human mitochondrial ceramidase
70. Biochemical characterization of the reverse activity of rat brain ceramidase: A CoA-independent and fumonisin BI-insensitive ceramide synthase
71. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology
72. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis
73. Mouse anti-ceramide antiserum: A specific tool for the detection of endogenous ceramide
74. A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: Potential implications in tumour necrosis factor signalling
75. 1
76. Influence of bax or bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells
77. Protective role of Bcl-2 in metabolic oxidative stress-induced cell death
78. p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells
79. Ceramide induces aSMase expression: Implications for oxLDL-induced apoptosis
80. Endothelial Apoptosis as the primary lesion initiating intestinal radiation damage in mice
81. Stress-induced apoptosis is not mediated by endolysosomal ceramide
82. Killing cancer cells by poly-drug elevation of ceramide levels: A hypothesis whose time has come?
83. Induction of the manganese superoxide dismutase gene by sphingomyelinase and ceramide
84. Measurement of ceramide synthase activity
85. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis
86. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine
87. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria
88. N-(4-Hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase
89. Targeting ceramide metabolism - A strategy for overcoming drug resistance
90. The involvement of sphingolipids in multidrug resistance
91. Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy
92. Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide
93. Sphingomyelin potentiates chemotherapy of human cancer xenographs
94. Ceramide glycosylation potentiates cellular multidrug resistance
95. Glucosylceramide: A marker for multiple-drug resistant cancers
96. Elevation of glucosylceramide in multidrug-resistant cancer cells and acculumation in cytoplasmic droplets
97. Identification of active site residues in glucosylceramide synthase
98. Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens
99. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein
100. Differential expression of sphingolipids in MRPI overexpressing HT29 cells
101. The role of different P-glycoproteins in hepatobiliary secretion of fluorescently labeled short-chain phospholipids
102. The human multidrug resistance protein MRPI translocates sphingolipid analogs across the plasma membrane
103. 6-fold increased cell sensitivity to Verocytotoxin
104. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway
105. Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: Influence of drug transport abnormalities
106. Upregulation of caveolin in multidrug resistant cancer cells: Functional implications
107. Glucosylceramide synthase inhibition exhances vincristine-induced cytotoxicity
108. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism
109. Combined cytotxic action of paclitaxel and ceramide against the human Tu 138 head and neck squamous carcinoma cell line
110. Sphingomyelin potentiates chemotherapy of human cancer xenografts
111. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids